Abstract:Among patients with HCC who received immunotherapy, lower NLR, and MLR at baseline in overall patients were significantly associated with better disease control and more favorable survival outcomes (both OS and PFS), and lower PLR was significantly associated with longer PFS. The findings of this research may offer useful hints for an optimized selection of patients with liver cancer who may benefit more from immunotherapy. Background Peripheral blood immunomarkers are associated with prognosis in patients with solid tumors receiving chemotherapy or immunotherapy. In this study, the associations of circulating neutrophil‐to‐lymphocyte ratio (NLR), monocyte‐to‐lymphocyte ratio (MLR), and platelet‐to‐lymphocyte ratio (PLR), as well as their dynamic changes were investigated in relation to the efficacy of immunotherapy in patients with primary liver cancer. Methods Comparisons were made between NLR, MLR, and PLR among individuals exhibiting disease control (defined as the best response of partial response [PR] or stable disease [SD]) and those with progressive disease (PD). Additionally, disease control rate (DCR), overall survival (OS), and progression‐free survival (PFS) were compared between individuals with different NLR, MLR, and PLR levels before initiating palliative immunotherapy. Furthermore, comparisons were made between patients with different alterations in the ratios at the second cycle of immunotherapy compared to baseline. These analyses were performed using univariate and multivariate approaches. A total of 119 Chinese patients with liver cancer who underwent immunotherapy were included in this study, which focused on hepatocellular carcinoma (HCC). Results In cases with HCC (n = 104), the cutoffs of NLR, MLR, and PLR to differentiate treatment responders from nonresponders were 3.38, 0.28, and 227.18, respectively. Patients with the best response of PR or SD had significantly lower NLR and MLR. Patients with NLR <3.38 and those with MLR <0.28 significantly had longer OS and PFS than their counterparts, and those with PLR <227.18 had significantly longer PFS, both in overall patients and in various patient subgroups. Lower NLR, MLR, or PLR was associated with earlier BCLC stage, fewer metastatic sites, less frequent extrahepatic metastasis, or better performance status. For individuals who had an unfavorable baseline NLR ≥3.38, MLR ≥0.28, or a favorable baseline PLR <227.18 prior to first immunotherapy, a decrease in NLR, MLR, or PLR at Cycle 2 of immunotherapy was significantly associated with a higher DCR. Conclusions Among patients with HCC who received immunotherapy, lower NLR, and MLR at baseline in overall patients were significantly associated with better disease control and more favorable survival outcomes (both OS and PFS), and lower PLR was significantly associated with longer PFS. The findings of this research may offer useful hints foranoptimized selection of patients with liver cancer who may benefit more from immunotherapy.

Analysis of the phenotypes of immunological cell in patients with Primary Liver Carcinoma pre- and post-hepatectomy

Immunohistochemical Study of Pcna and P53 in Primary Liver Cancer - an Implication for Prognosis and Treatment

THE CHANGES OF PERIPHERAL BLOOD T LYMPHOCYTE SUBSETS IN PATIENTS WITH PRIMARY HEPATIC CARCINOMA BOTH PRE-TACE AND POST-TACE

Effect of hepatic resection on surface phenotypes of peripheral blood lymphocytes in patients with hepatocellular carcinoma

Clinical Significance Of Preoperative Platelet-To-Lymphocyte Ratio In Recurrent Hepatocellular Carcinoma After Thermal Ablation: A Retrospective Analysis

Study on quantity and function of peripheral blood NK cell subsets in primary liver cancer

Role of serum lactate dehydrogenase in prognosis of primary liver cancer in patients undergoing transarterial chemoembolization

A High Preoperative Platelet-Lymphocyte Ratio is a Negative Predictor of Survival after Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Study.

Preoperative platelet count in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy

Effects of Transcatheter Arterial Chemoembolization on Immune Function in Patients with Primary Liver Cancer

Effect of Laparoscopic Hepatectomy on Cellular Immunity

Expression of T cells surface marker LAP in peripheral blood of hepatocellular carcinoma and its significance

Detection of Immune Cell Subsets of Peripheral Blood in Hepatocellular Carcinoma before Liver Transplantation

Clinical Analysis of Interventional Therapies for Primary Liver Cancer

Study on the tumor infiltrating T lymphocytes subsets in HCC patients

Expression and Clinical Significance of TAp73α, P53, PCNA and Apoptosis in Hepatocellular Carcinoma

Primary liver cancer complicated with non-Hodgkin’s lymphoma：two cases analysis and literature review

Associations of circulating immunomarkers with the efficacy of immunotherapy for primary hepatic carcinoma

Negative Impact of Preoperative Platelet-Lymphocyte Ratio on Outcome after Hepatic Resection for Intrahepatic Cholangiocarcinoma.

Analysis of Prognostic Factors in Primary Clear Cell Carcinoma of the Liver Postoperation

Hepatic Histopathology and Postoperative Outcome after Preoperative Chemotherapy for Chinese Patients with Colorectal Liver Metastases.